A Biotech Executive Faces End-Stage Cancer As A Patient

  • 📰 Forbes
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 53%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

On stage now at the ForbesHealth summit: Michael D. Becker, whose story you can read here:

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca's ovarian cancer and anemia treatments meet goals in late-stage studiesBritish drugmaker AstraZeneca on Thursday said its ovarian cancer and anemia tre... RT : AstraZeneca's ovarian cancer and anemia treatments meet goals in late-stage ... I guess they used the $4.9 billion in Seroquel sales for R&D of this drug.
Source: Reuters - 🏆 2. / 97 Read more »

Commentary: How Patients Have Transformed A Medical Meeting About Breast CancerAdvocates have become an essential part of the annual San Antonio Breast Cancer Symposium, an influential medical meeting. Former oncologist Elaine Schattner explains the change and its importance. Here's a thought. Well over 50% of ALL Cancer research funding is being spent on Women's Cancers, the Vast bulk of that on Breast Cancer. Why does this one Cancer so dominate ALL Research?!!
Source: NPR - 🏆 96. / 63 Read more »